- Report
- June 2020
- 112 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- November 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- October 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- February 2023
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- November 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- August 2022
- 120 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- January 2019
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- August 2022
- 236 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 245 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 258 Pages
Middle East, Africa
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 273 Pages
Europe
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 268 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 110 Pages
Europe
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 112 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- August 2022
- 102 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- May 2022
- 347 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- May 2022
- 152 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
The Metered Dose Inhaler (MDI) market is a subset of the larger Inhalers and Nebulisers market. MDIs are a type of inhaler that dispenses a measured dose of medication in aerosol form, which is then inhaled into the lungs. MDIs are the most commonly used type of inhaler, and are used to treat a variety of respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). MDIs are typically small, portable, and easy to use, making them a popular choice for patients.
MDIs are typically composed of a pressurized canister containing medication, a metering valve, and an actuator. The canister is filled with a propellant, which is used to expel the medication from the canister. The metering valve is used to control the amount of medication that is released, while the actuator is used to deliver the medication to the patient.
The MDI market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck, and Novartis. Show Less Read more